Trial Profile
Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin aspart (Primary) ; Insulin; Insulin detemir; Insulin glargine; Metformin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Onset 3
- Sponsors Novo Nordisk
- 05 Oct 2018 Results (n=236) of post-hoc analysis presented at the 54th Annual Meeting of the European Association for the Study of Diabetes
- 08 Dec 2017 Results of a post-hoc analysis from Onset-2 and Onset-3 studies, presented at the 2017 Congress of the International Diabetes Federation
- 08 Dec 2017 Results of a post-hoc analysis presented at the 2017 Congress of the International Diabetes Federation.